mechanism of action of glp-1 receptor agonists as Treatments for Type 2 Diabetes Mechanisms of action of GLP-1RA.

Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)

Because these drugs are temperature-sensitive biologics, traditional pill-in-a-bottle packaging is insufficient

doi: 10.3390/ijms21093165 14 DubeySKLakshmiKKKrishnaKVAgrawalMSinghviGSahaRNet al

Health technology evaluation: the NICE road map

Additionally, with ongoing research and positive clinical results, oral GLP-1 drugs are anticipated to gain broader acceptance among healthcare providers and patients alike

Tirzepatide has been shown in clinical trials to reduce the risk of cardiovascular events at various doses, suggesting a potential treatment option for patients who are obese or overweight [2]